Treatment outcome
Analysis of treatment outcomes in the modified intention-to-treat population showed that a sustained treatment success occurred in 41.3% (19/46) and 70.2% (33/47) of the patients who received the PRS regimen and standard regimen, respectively, for an absolute difference of 28.9 percentage points (95% CI, 9.6–48.2; 